According to the charity, the fire broke out in an adjacent building in the early hours of the morning and caused considerable damage before it was put out by the fire brigade.
Luckily, the building was unoccupied at the time and nobody was hurt.
Structural damage was caused to the building and the charity reports that much of its office contents were damaged or destroyed by fire, smoke or water, including its servers.
However, because of coronavirus, the charity had already put systems in place to operate remotely, so it expects to continue service more or less as normal.
One set of guidelines deals with intoxication from pyrethrins commonly found in flea control products or ant powders, whilst the other covers macrocyclic lactone poisoning which most often occurs due to accidental ingestion of large animal anthelmintic products.
Both intoxications are commonly associated with severe neurological symptoms.
Will Peel, Product Manager at TVM UK said: "Our guidelines have proved very useful to veterinary staff and we have received requests from vets to add new guidelines for antiparasiticide intoxications. Our focus is on helping veterinary staff provide the best possible care for their patients so we hope that these new guidelines will prove beneficial."
The guidelines can be downloaded free from https://www.tvm-uk.com/vet-resource-library.
BEVA Congress 2021 will now take place from September 4th-7th 2021.
The decision to cancel Congress 2020 was taken by BEVA Council and the Congress programme committee because of the unpredictable circumstances of the coronavirus pandemic.
Tim Mair, President of BEVA said: “The overriding factor in our decision-making process was to protect everyone attending Congress. We are chartering unknown territory at the moment and the additional planning requirements needed to run a large event like BEVA Congress with social distancing measures in place will take time.
“We intend for September 2021 to mark an exciting, fresh start for the profession following the harrowing experiences of 2020. It should be safe for our international speakers and delegates to attend by then, getting us all back on track with networking and world-class CPD to inspire us for the new post Covid-19 world.”
Tickets for BEVA Congress 2021 will be available later this year, more information from: www.bevacongress.org.
In what is believed to be a first for the profession, a group of experts have joined forces to publish 'Chronic Pain in the Dog', a blog about managing pain.
The blog, which is sponsored by Vetoquinol and available exclusively to VetSurgeon.org members, offers opinions and advice from Dr Jo Murrell, BVSc PhD CertVA DipECVA MRCVS, Head of Anaesthesia at Bristol Vet School, Kate L White MA Vet MB DVA Dipl ECVAA MRCVS, European Specialist in Veterinary Anaesthesia & Analgesia, Associate Professor in Veterinary Anaesthesia and Clinical Sub Dean at Nottingham University Veterinary School and Krista Visser 't Hooft, DVM, DipACVIM (Internal Medicine), MRCVS, Specialist in Medicine.
A new blog entry is posted every few days, and each one focuses on just one aspect of pain management, to make it easy to digest in a busy day. The aim is to help build the clinician's understanding of the topic over time.
It is also hoped that the blog will build into a useful information resource, both to raise awareness of pain management and aid clinicians in making decisions about how to approach complex cases.
VetSurgeon members can subscribe to be alerted to new blog entries by email, and (at the time of writing) there is a prize of a £10 Amazon voucher for every 50th veterinary surgeon to do so.
Click here to read the blog and subscribe.
Dechra Veterinary Products has launched www.canine-cushings.co.uk, a new website for owners of dogs with Cushing’s syndrome, to support the advice given by their veterinary surgeon.
The new site contains information and resources designed to support dog owners whose pets have been prescribed Vetoryl. It looks at symptoms, diagnosis and treatment options, and owners can register for interactive treatment log book.
Craig Sankey, Brand Manager at Dechra Veterinary Products, said: "Diagnosis can be worrying for owners and the aim of the website is to help increase knowledge surrounding Cushing’s syndrome.
"The interactive treatment log book can be used by owners to chart progress and provide reassurance about how their dog is responding to Vetoryl therapy."
Zoetis Business Consulting has released figures showing that Profit Solver, its financial analysis tool, has delivered an average EBITDA (earnings before interest, taxes, depreciation and amortization) growth of 36% for the 28 UK practices that have used the new service since its launch.
Profit Solver was first launched in the USA, where the company says more than 300 practices have now benefited from the service.
Zoetis says that traditionally, veterinary practices have set their prices by simply adding a set mark-up, without knowing which services make a profit or loss and without understanding exactly how overall practice profit is being generated.
Profit Solver instead uses the practice’s own data to calculate the exact cost for the 130 most commonly performed veterinary services, representing 90% of the revenue generated by the practice. It then combines labour, inventory and equipment costs with time-and-motion studies for each service, and assesses the variance between cost and price to reveal profit or loss.
By using a collection of cost data, which staff perform which part of the procedure, how long the procedure takes and what equipment and materials are used, Profit Solver calculates the correct pricing to both cover costs and deliver a pre-determined profit margin.
Implementing Profit Solver is done with a Zoetis business consultant who guides the practice through the process, from data collection to examining the time-and-motion studies. They discuss the level of profitability the practice needs to deliver and help analyse prices to achieve this goal whilst preserving the price-point of highly competitive services and covering all the practice’s costs.
Ian Camm, Group Director of B&W Equine Vets in Gloucestershire heard about Profit Solver from a vet in a neighbouring practice who was impressed with how it had helped his business. Ian discussed Profit Solver with his Zoetis account manager and booked an appointment with Zoetis Business Consultant Anthea Pike who has helped him implement the software across B&W Equine Group.
He said: "Initially I was concerned that Profit Solver would suggest we put prices up where we felt that we would not be able to - people shop around for their veterinary services these days and many services are very price sensitive. The first stage in the process addressed this by looking at our figures, calculating the cost price for each procedure and then, by comparing with our fees charged, identified where we were losing money. The big question was whether we would be comfortable to increase our fees on loss-making procedures. The beauty of the system was that by looking at a large number of procedures which were done frequently, very small increases in fee would total to a significant improvement in the bottom line.
"The software has made us recognise where the real costs are and how to address these areas accordingly, for example we have identified that current stud packages are not profitable. One of the problems in arriving at true costs is the difficulty in accurately allocating time to various procedures when several different vets are involved or an expensive scanner is used, which can have a significant impact on the results. It’s early days, but I can already see the difference that Profit Solver could make to our bottom line and wouldn’t hesitate to recommend it providing the practice is prepared to make changes in light of the results. We are looking at improving our bottom line by a six figure sum over a 12 month period with what we hope, will be hardly noticeable price rises.”
For further information visit www.zoetis.co.uk/businessconsulting.
Advance25 Courses provide 25 hours of CPD in important areas of small animal practice, including Small Animal Medicine Cases Challenges, Emergency Medicine, Abdominal Ultrasound and Thoracic and Abdominal Radiology.
Advance25 courses run for a 6 week period, with tutor support. Recorded and live sessions are combined with discussion of multiple cases. Course materials are then accessible for 12 months.
Susie Coughlan, Managing Director of CPD Solutions said: "We appreciate that there is a high demand for quality online options at the moment, with many vets limited to online CPD.
"With the new Advance25 courses we’ve added more tutor support and ongoing interaction for those who are looking for a more immersive experience providing extended CPD hours. We’re really excited about these courses, which are launching now and running in the autumn. They should help vets make a real difference in their practices; they’re fully flexible and will fit with many people’s family and work commitments.’
For more information and to enter a prize draw to win a free Advance25 course, visit: https://www.cpd-solutions.com/advance25
Swindon-based Eastcott Veterinary Referrals is looking for a new resident to join its dentistry team.
Eastcott’s dentistry department is led by Andrew Perry, an EBVS European Veterinary Specialist in Dentistry. He's supported by Peter Southerden, AVDC Founding Fellow in Oral and Maxillofacial Surgery – one of only 14 founding fellows in the world and the only one practicing in Europe.
The residency programme will offer an in-depth knowledge in veterinary dentistry through a mix of clinical and non-clinical work.
It will also provide an opportunity to work alongside world class surgeons responsible for some of the most advanced dental surgical procedures of today.
The clinical aspect of the role will require the candidate to manage cases and perform all forms of dental and oral surgical procedures and client communication, with guidance from senior staff.
The role will also involve preparation of scientific articles for publication and will help develop the candidate's teaching and presenting skills and externships in diagnostic imaging, surgery and anaesthesia.
Andrew said: “The team at Eastcott are proud to be a part of developing future specialists in a discipline that is growing rapidly and has such an impact on patient welfare.
“Our multidisciplinary approach to management of dental, oral and maxillofacial pathologies means that the successful candidate will have the benefit of exposure to a very diverse, and at times cutting edge, caseload.
“The residency programme is well-established at Eastcott. The dentistry, oral and maxillofacial team, the hospital directors and the Linnaeus central support team are committed to individual development and growth and work hard to provide an environment and support to allow our residents to flourish.”
For more information on this role, visit www.eastcottreferrals.co.uk or email andrew.perry@eastcottvets.co.uk before July 31.
Vetoquinol has announced that packs of Rubenal 300mg are now available in bottles of 60 tablets instead of the previous 20.
Rubenal, which was launched earlier this year, is a complementary nutritional feeding stuff for the support of renal function in case of chronic renal insufficiency in dogs and cats. It is used as an aid to the maintenance of the normal renal fibrous architecture.
Simon Boulton, Rubenal's product manager said: "This increased pack size is a direct result of customer consultation. It will make treatment more cost effective for dogs and allow a longer treatment period per pack purchased."
For further information please contact your Vetoquinol representative or telephone 0800 1698197.
CEVA Animal Health has published a trial which, according to the company, shows that horses suffering lameness caused by bone spavin can show marked improvement following treatment with a Tiludronate infusion, in combination with controlled exercise.
Bone spavin is a chronic aseptic osteoarthritis of the distal tarsal joints which, says CEVA, is considered to be one of the most common forms of hindlimb lameness in the horse.
The double-blind, multicentric, placebo-controlled trials were carried out on a total of 108 pleasure horses, show jumpers and eventers of a variety of sizes and breeds, all of which had been clinically diagnosed with bone spavin. The horses were rigorously selected, having to show clinical signs of spontaneous lameness of at least six weeks but less than a year's duration and had to be in daily exercise. Horses suffering proximal suspensory desmitis were excluded.
Horses were defined as suffering from bone spavin if they displayed a chronic hindlimb lameness which improved with distal tarsal joint analgesia and showed radiographic evidence of bony changes associated with bone spavin in the distal tarsal joints. The horses were treated at day zero with a single Tiludronate infusion or a placebo and reassessed 60 days later after a period of controlled exercise.
Eighty seven horses completed the trials, comprising 42 Tiludronate treated horses and 45 placebo cases. By day 60 approximately 60% of the Tiludronate treated horses had improved in lameness by two grades or more, scored on a ten point system.
Horses with bone spavin experience abnormal bone remodeling changes, occasionally with excessive bone resorption in the tarsal bones. Tiludronate works by regulating this bone remodeling through a decrease in the resorptive process, slowing down the degradation of the bone structure when the condition is progressing and alleviating the pain associated with abnormal bone lysis.
CEVA has recently produced a leaflet specifically to help horse owners to understand the diagnosis and treatment of bone spavin. For copies of this leaflet and CEVA's comprehensive veterinary brochure on the product please contact CEVA Animal Health on 01494 781510 or visit the website at http://www.tildren.com/
Tiludronate infusion in the treatment of bone spavin: A double blind placebo-controlled trial
Reference M. R. GOUGH*, D. THIBAUD† and R. K. W. SMITH‡ (*CEVA Animal Health, Bucks, UK; †CEVA Animal Health USA, Kansas, USA; and ‡Department of Veterinary Clinical Sciences, The Royal Veterinary College, University of London, UK). Equine vet. J. (2010) 42 (5) 381-387 doi: 10.1111/j.2042-3306.2010.00120.x
Novartis Animal Health has announced that it will begin marketing and distributing Adequan Equine in the UK from January 2011.
According to the company, Adequan Equine offers equine veterinarians a proven intramuscular treatment option for equine degenerative joint disease, also known as non-infectious arthritis or osteoarthritis. The product is licensed in the UK for the treatment of lameness in horses due to traumatic or degenerative aseptic joint disease and acute superficial digital flexor tendonitis. This is a critical treatment area since equine degenerative joint disease is estimated to cause up to one-third of all equine lameness cases1. It most commonly affects the hocks and coffin joints with the most severe effects on the high-motion knee and fetlock joints.
Esther Rawlinson MRCVS, Global Technical Services Manager for the Novartis Animal Health Companion Animal Business in the Therapeutics & Equine areas said: "Adequan Equine is a leading joint treatment for horses and is widely used by veterinarians in the equine sport industry. Adequan Equine reduces pain and lameness in horses while at the same time stimulating cartilage repair.
Adequan Equine 100mg/ml solution contains polysulphated glycosaminoglycan for intramuscular injection. It is a chondroprotective, meaning it inhibits the breakdown of cartilage in diseased joints while at the same time supporting its repair.
Adequan Equine works by blocking the destructive enzymes formed in the joint as a result of inflammation while stimulating the production of hyaluronic acid to restore the synovial fluid, and the synthesis of cartilage building compounds.
Boehringer Ingelheim has announced that its 'Talk About Laminitis' campaign will run from Mid March until the end of June.
Last year, the initiative saw over 9000 horses and ponies tested for PPID through its free ACTH test scheme. This year, to build on this success and support the testing of even more animals, the company has announced a high impact, co-ordinated campaign to drive awareness that up to 90% of laminitis cases may have an underlying endocrine cause1,2.
Once again, Boehringer is urging veterinary surgeons to carry out free ACTH blood tests on laminitic or foot-sore horses as part of the campaign, which is backed by Redwings, The British Horse Society and World Horse Welfare.
Professor Andy Durham from the Liphook Equine Hospital, where the ACTH tests are performed, said: "We are learning so much from these tests. For example, we are now recognising PPID routinely in laminitic horses and ponies as young as 10 years old, and in the spring when we might expect to see more EMS cases, where veterinary surgeons have also tested for PPID we are seeing both abnormally elevated ACTH and insulin. Unless the PPID is addressed, horses will continue to be at risk of painful recurrent laminitic episodes which is a significant welfare issue to the horse and extremely frustrating for owners."
To participate in the scheme, veterinary surgeons and horse owners can download ACTH blood test vouchers from www.talkaboutlaminitis.co.uk. Attach the voucher to the ACTH sample submission form and the ACTH laboratory fees will not be charged.
Lee Hackett from The British Horse Society said: "Without the 'Talk About Laminitis' initiative and the support of Boehringer Ingelheim, literally thousands of horses may not be receiving the appropriate treatment and management for their laminitis to help prevent recurrence. We hope as many veterinary surgeons as possible get involved this year to continue this welfare success."
To ensure that horse owners are fully aware of the initiative, a PR and advertising campaign in the equine consumer media will start in March. The ad campaign includes an infomercial on Horse & Country TV (SKY Channel 280), with viewer numbers in excess of 450,000 per month.
There will also be a live online broadcast for horse owners on endocrinopathic laminitis presented by David Rendle BVSc MVM CertEM(IntMed) DipECEIM MRCVS, from the Liphook Equine Hospital in Hampshire. The one-hour webinar, which takes place at 8.00pm on Wednesday 10 April, will educate horse owners on how the veterinary profession's understanding of this debilitating and devastating disease has been completely revolutionised over the past five years. It will be followed by an interactive Q&A session when viewers will be able to pose questions for David to answer.
David said: "As our knowledge of the two hormonal diseases responsible for the majority of cases of laminitis improves, veterinary surgeons can offer their clients more comprehensive advice on treatment options to prevent laminitis. For many owners who have struggled with this condition, this is an absolute revelation and has enormous welfare benefits".
Horse owners can register to view the online programme by visiting www.talkaboutlaminitis.co.uk.
To ensure that veterinary surgeons are versed in the most up to date research available, Boehringer Ingelheim will also be hosting a webinar for veterinary professionals at 8.00pm on Wednesday 13th March, presented by Professor Andy Durham BSc BVSc CertEP DEIM DipECEIM MRCVS. The online seminar, 'The laminitis revolution.... An update on our understanding of endocrinopathic causes of laminitis', will entitle the viewer to a downloadable certificate for one hour of CPD. To register, visit www.bi-academy.co.uk. Places are limited, so register early to avoid disappointment. The webinar will also be available to view after the event on demand.
For further information on how you can promote 'Talk About Laminitis' in your practice contact your Boehringer Ingelheim Territory Manager or call 01344 746959
References
1. Karikoski et al. (2011). The prevalence of endocrinopathic laminitis among horses presented for laminitis at a first-opinion/referral equine hospital. Domestic Animal Endocrinology 41 111-117
2. Donaldson et al. (2004). Evaluation of suspected pituitary pars intermedia dysfunction in horses with laminitis. J Am Vet Med Assoc;224:1123-1127.
Royal Canin has announced that it has established a team of three specialist advisors to work directly with veterinary practices to help develop and improve their weight management clinics, client retention and product sales.
The Pet Weight Care Team will also provide practical training to all practice staff on how to recognise weight problems, communicate sensitively with pet owners and treat the problem effectively.
The first advisor to join the team is Shelley Holden VN (pictured right), who has 10 years' experience as the nurse for the Royal Canin Weight Management Referral Clinic at The University of Liverpool. Shelley has spent time running successful nursing clinics in general practice and lecturing internationally on the topic of obesity. She said: "I have spent many years dedicating my time caring for overweight pets, and the number of cases we see is continuing to rise. It's really important that as obesity specialists we can offer hands-on support to practices to assist them with helping to decrease the number of overweight pets they see.
"Our aim will be to offer specialist training through a number of sessions to practices who wish to improve their weight management clinics. We'll spend time with all members of staff helping them to feel more confident when dealing with owners who have overweight pets. The training will include all aspects of weight management including how to approach owners, Body Condition Scoring and the 30 minute consult. Staff will also be trained on how to support owners throughout the weight loss program and during the maintenance phase."
Royal Canin says the training will also cover the prevention of obesity in pets, how to advise owners on the appropriate diets post neutering and how to manage the animal's weight and calorie intake throughout their lives. The Pet Weight Care Team will be encouraging practices to carry out weight management assessments alongside medical examinations to ensure that potential weight problems are dealt with quickly.
The company says that practices that receive training will be followed up with on a regular basis to provide further support and training as needed.
For more information, contact your Royal Canin Veterinary Business Manager.
81% of equine worming strategies are not effective in fight against resistance, because owners are not conducting an adequate level of faecal egg counts (FEC), according to a survey carried out by Countrywide, the supplier of equestrian products.
The company surveyed nearly 1,000 horse owners in collaboration with Westgate Laboratories, Norbrook and BW Equine Vets and found that 47% have never conducted an FEC test.
When asked about their current approach to worming, 59% of respondents said they worm at set times of the year with only 31% conducting regular FEC tests.
Mark Hawkins, SQP at Countrywide, said: "With worms becoming resistant to some worming drugs, simply dosing all horses with routine wormers is not adequate. A targeted approach, which considers each horse as an individual, is needed."
Gillian Booth owner at Westgate Laboratories said: "The results show that the majority of horse owners are not updating their worming practice to match the increase in resistance and improvement in testing technology. Previous worming practices have led to the resistance problems we now have so it is vital that there is change."
The survey found that veterinary surgeons and in store advisors are vital to promote change - 65% of respondents actively seek advice from their vet and Suitably Qualified Person (SQP) for worming and general health care.
Mark added: “A huge 99% of people worm their horse at least once a year; despite this 38% of horse owners do not know an accurate weight of their horse. Considering inaccurate dosing plays a large role with the increase in resistance this figure is very concerning. If you do need to treat, accurate dosing is essential.”
The survey found that 86% of respondents had wormed for tapeworm, making it the most wormed for parasite. Despite this, only 6% of horse owners had conducted a saliva test for tapeworm, and only 8% had conducted the more established ELISA blood test through their vet to prove the need for this worming dose.
For a full breakdown of the survey results, visit: www.countrywidefarmers.co.uk/wormingsurvey.
Key Note Ltd, has published Pet Insurance 2015, a report into the state of the UK pet insurance market which forecasts that premiums will rise by 46.7% by 2019.
The report notes that the percentage of adults in Great Britain owning at least one dog has increased by 2.1 percentage points over the past 5 years, and the percentage owning at least one cat is 2.5 percentage points higher than it was 5 years ago. Yet despite growth in the pet population, the increase in the volume of pet insurance policies (23.6% between 2010 and 2014) has been far exceeded by the increase in the value of premiums written (40.7%).
Key Note says claims inflation has been a major factor in rising premiums; despite gross written premiums for cats, dogs and other pets increasing by 13.3% between 2013 and 2014 alone, the cost of claims for the same animals rose by 14.7% over the same period, over and above the premium increases seen.
According to the company, rising claims are largely down to the increasing cost of veterinary treatment — as advances in pet medicine increase apace with those in human medicine, treating pets is getting more costly. Not only this, but other factors, such as the rise in overweight or obese pets and even antibiotic-resistant bacteria, both common problems in the human health service, are also pushing up the costs of veterinary treatment.
In other general insurance markets, most notably motor insurance, which price comparison websites (PCWs) were initially set up to focus on, competition exerts a major downward pressure on premiums. However, the report says this is not always the case in the pet insurance market. This is because it can be difficult for those who have already claimed on pet insurance policies to switch insurers; the result of doing so is often that the condition the pet has previously been treated for is classed as ‘pre-existing’ in the new policy and therefore it, and related conditions, will not be covered under the new policy. This could leave pet owners liable to pay for veterinary treatment in full.
The situation has been further exacerbated by the high-profile withdrawal of a number of underwriters from the pet insurance market. The nature of the pet insurance market, though at first seeming diverse, actually involves a relatively limited pool of underwriters behind the numerous brands available. The report details how just four underwriters between them either underwrite or, at the very least, arrange and administer the pet insurance policies of 27 of the foremost brands in the pet insurance market.
Key Note forecasts that although insurance companies will see an increase in the volume of pets insured, this will not compensate for the relentless increase in the cost of claims which will be largely responsible for driving the cost of pet insurance up 46.7% by 2019.
All existing BEVA members will have their membership automatically extended until 30 June 2020. The association is also inviting vets and vet nurses who are not already BEVA members to join as online members free of charge until 30 June 2020.
BEVA President Tim Mair said: “In this extraordinary time of global crisis our profession, as with many industries, is under immense pressure. By offering free membership we are giving equine vets easy access to a wealth of supportive resources and online CPD to help them through these dark times.”
BEVA membership includes:
The association is also looking at other ways to support the profession, which has included making all BEVA Congress 2019 webinars available to members via the BEVA online learning platform.
To sign up from Monday 30 March 2020 visit: https://www.beva.org.uk/Join-BEVA
In order to prevent tail injury in one dog you'd need to dock 500, according to research published in this week's Veterinary Record.The study1 was based on 138,212 dogs seen by vets at 52 veterinary practices across Britain between March 2008 and March 2009. 281 were treated for a tail injury - a rate of 0.23%, adjusted for sampling. The owners of 224 of these injured dogs, as well as a random sample of 799 owners whose dogs had not been treated for tail injury were sent a questionnaire on dog tail injuries and docking.Only 97 of the owners whose dogs needed treatment and 227 of those whose dogs had not been injured replied.Their responses indicated that around one in three tail injuries (36%; 35 cases) had occurred at home as a result of the dog knocking its tail against a wall, kennel wall or other household object.A further 17.5% (17 cases) were sustained outdoors, while 14.4% (14 cases) were caused by the tail being caught in a door. In 15 (15.5%) other causes were cited; and in 16 (16.5%), the cause was unknown. Almost half of the injuries (44%) were recurrent.Over half the cases were treated with drugs and dressings, but in almost one in three cases, amputation was required. Eleven dogs did not need any treatment.Certain breeds seemed to be more at risk, with springer and cocker spaniels almost six times as likely to sustain a tail injury as labradors and retrievers. Greyhounds, lurchers, and whippets were almost seven times as likely to do so, possibly because of the lack of protective hair on their tails, say the authors. Dogs with a wide angle of wag were also almost four times as likely to be injured in this way, while dogs kept in kennels were more than 3.5 times as likely to sustain a tail injury. Only 35 owners said their dogs had had their tail docked, and on the basis of their overall findings, the authors calculated that tail docking would reduce the risk of injury by 12%.But in absolute terms, 500 dogs would need to have their tail docked in order to prevent one tail injury.
Reference1Risk factors for tail injuries in dogs in Great Britain. G. Diesel, D. Pfeiffer, S. Crispin, and D. Brodbelt. The Veterinary Record 2010 166: 812-817.
Simon Dennis, lecturer in cardiology and Rob Goggs, staff clinician in emergency and critical care, both from the Royal Veterinary College have completed a gruelling four day charity bicycle ride from London to Paris.
The bike ride was in aid of Action Medical Research (AMR), a medical research charity dedicated to helping babies and children through tackling premature birth and treating sick and vulnerable babies; helping children affected by disability, disabling conditions and infections; and targeting rare diseases that severely affect many forgotten children.
The cycling duo is aiming to raise £3,000 for this cause and have already raised about £2,400.
The race ended with 600 other cyclists riding in unison through the centre of Paris, with the watching crowd cheering the cyclists on from the streets and cars.
Simon Dennis said: "Both Rob and I are extremely pleased to have completed the cycle ride and raise money for such a worthy cause. It was a tough four days, but definitely worth it in the end, as it was an incredible once in a lifetime experience for us both."
"We would like to thank everyone for their donations, but particularly CEVA Animal Health and Boehringer Ingelheim, who were both really generous sponsors to the charity."
If you would like to donate money to this cause please visit http://www.action.org.uk/sponsor/sgdennis
VetSurgeon member Viki Edmondson MRCVS is taking part in a drive to help 13-year-old Octavia Woodward, who was born with spinal muscular atrophy (SMA), raise £100,000 to help The SMA Trust.
Viki, a well-known vet in the carriage driving world, will be joining Octavia on 'Octavia's Mad Marathon', a five-day, 110 mile carriage drive from Windsor to Wincanton.
Octavia will be driving her pony, Diddy, with her mother Henrietta as co-driver. Meanwhile, Viki will be driving a pair of Gelderlander horses. They'll be leaving the main ring at the Royal Windsor Horse Show with a support crew at 3:30pm on 13th May.
Viki graduated from Bristol Veterinary School in 1993. Since 2001 she has run her own equine practice plus a small animal surgery from the Newdigate, Surrey farm she shares with husband Peter. Viki has known Octavia since she was born and it was Viki who paired up Diddy with Octavia and encouraged her to progress from walking round the roads to the excitement of "off-roading". Viki will be providing support and encouragement to Octavia during the trip - of course with any veterinary help being close by.
To support Viki and Octavia, visit: http://www.justgiving.com/vikithevet
Ceva Animal Health has highlighted a new meta-analysis1 which, according to the company, reveals that there is a significant (P< 0.001) association between the use of pharmacotherapy (fluoxetine and clomipramine) or pheromonatherapy (Feliway) and reduction or elimination of feline urine marking.
Ceva says this is the first time a meta-analysis technique has been used to evaluate the efficacy of interventions in veterinary behavioural medicine; the study assessed all published papers covering treatments for feline urine spraying. Ten studies in nine publications were analysed, despite their different study designs. In order to carry out the meta-analysis, the papers were rated according to importance and a 'placebo-effect' was calculated. Primary and secondary outcomes were also identified, with the primary outcome being the 'number of cats that either ceased or reduced spraying by at least 90%' and the secondary outcome being 'the number of cats that reduce spraying from baseline levels'.
Information is available by calling Lucy Brett at CEVA Animal Health on 01494 781510.
1. A meta-analysis of studies of treatments for feline urine spraying. Daniel S Mills, Sarah E Redgate, Gary M Landsberg. PLos ONE, April 2011, Volume 6, Issue 4
Her Royal Highness, the Princess Royal opened a new ward for canine cancer patients at the University of Edinburgh's Royal (Dick) School of Veterinary Studies Hospital for Small Animals last week.
The Kennel Club Charitable Trust provided £30,000 towards the 26-kennel ward, which is specifically designed to provide recuperative care and comfortable kennelling facilities for dogs at the University's Hospital for Small Animals.
The facilities the new dog ward provides will complement the School's £3 million Riddell-Swan Veterinary Cancer Centre, which opened last year. The cancer care centre houses state-of-the-art equipment including a computerised tomography (CT) scanner and a linear accelerator that can provide radiotherapy treatment.
Caroline Kisko, Secretary of the Kennel Club, said: "The Kennel Club Charitable Trust is extremely pleased that the money it has given to the University of Edinburgh has helped to ensure that its Canine Cancer Care unit could be built.
"The Trust has supported the groundbreaking research being conducted by the University, which is helping to improve our ability to diagnose and treat cancer in dogs, for some time. The Cancer Care Unit will help in a different way, by providing post-treatment and after care for dogs that have been through cancer therapy.
"People love their dogs as a member of their family, so this is a vital part of the care process. It is comforting for them to know that there are comfortable kenneling facilities where their dogs will receive the recuperative care that they need, as well as the potentially life-saving treatment.
"The Charitable Trust has given millions of pounds to projects which help to improve the health and welfare of dogs across the UK. This unit has established the University's place as a leader in conducting not only lifesaving but also life enhancing work for dogs, and the Trust exists precisely to help projects such as this realise their goals."
The canine oncology support ward replaces the old feline ward, and the cats have been moved to a new ward further away from the dogs to help prevent cats from becoming stressed by the noise of barking.
Professor Elaine Watson, Head of the Royal (Dick) School of Veterinary Studies said: "The dog ward, along with our new feline ward enhances the facilities for animals receiving treatment at the School's Hospital for Small Animals and we are very appreciative of the tremendous support from the Kennel Club Charitable Trust."
The Animal Medicines Distributors Association (AHDA) and the Animal Medicines Training Regulatory Authority (AMTRA) have both come out against the BVA's call for all anthelmintic medicines to be reclassified as POM-V, which would prevent them being prescribed by Suitably Qualified Persons (SQP).
Ian Scott, Secretary General of AHDA, said that instead of launching an attack on SQPs, the BVA should be working with them and animal owners to tackle anthelmintic resistance: "The BVA has written to the VMD to ask that all anthemintics be classified to POM-V only. This will monopolise the supply and distribution of anthelmintics for vets only. It effectively places the blame for anthelmintic resistance squarely on SQPs.
"An attempt by BVA to create a division between vets and SQPs demonstrates that the BVA is out of touch with its members.
"Both prescribing channels must work together to tackle the problem and AHDA has been working hard with vets at national and local level to ensure customers receive consistent, high quality, up-to-date and relevant advice from both channels.
"What is worrying is that the BVA attack also infers that farmer producers and equine owners are incapable of making decisions that not only affect their livelihood but cast doubt on their ability to care for their animals' welfare."
Meanwhile, Stephen Dawson, Secretary General of AMTRA said: "The large majority of SQPs deal with parasite control on a daily basis, having trained and been examined to a syllabus developed with BVA input. SQPs have to undertake compulsory continuing professional development, the majority of which includes good practice in parasite control. Therefore AMTRA has every confidence that qualified SQPs have excellent knowledge of parasitology to advise their clients on the correct choice and use of anthelmintics.
"It is important to recognise the hard work, knowledge and dedication of thousands of SQPs throughout the UK. The implication of what BVA say is that they are laying a proportion of the blame for resistance to these medicines at the door of SQPs. But the evidence isn't there: countries in Europe and elsewhere with different prescription systems, mainly though vet-only channels, still have major resistance problems. Prescription of antimicrobials by veterinary surgeons hasn't prevented concerns about prescribing practices and developing resistance. The key point is good advice from the prescriber and how they are then used in practice, rather than who prescribes them. The challenge for us all is not just to seek excellence in prescribing but also in usage on farm, something SQPs are ideally placed to do with their frequent farmer contact.
"I would urge all parties to work in partnership to ensure that best practice in prescription and use is followed by all prescribers and users. It is up to all prescribers to act responsibly, but to single out one group over another is unjustified. A pseudo-monopoly by vets on supply would do nothing to help farmers in difficult times."
Mr Dawson also expressed doubts about permanent POM-V status for new livestock anthelmintics: "While we fully support VMD's and VPC's need to be sure that the risk associated with wider availability of a new product is low, AMTRA considers that the current division in distribution classes and consequent low uptake of the newer products means that the much bigger risk is that widespread reliance on the three aging classes may be followed by reliance on just the two new classes when the older classes become unusable. Much better to have responsible prescription of all five classes now, by appropriately trained SQPs, vets and pharmacists, to ensure that there is a prospect of long term availability of effective parasite control."
BVA Past President Peter Jones is appearing before an All Party Parliamentary Group (APPG) on Antibiotics today, to update parliamentarians and stakeholders on the efforts the association and the profession are making to tackle the issue. Speaking to the APPG, Peter will say: "We know that the biggest cause of antibiotic resistance in humans is the overuse and misuse of antibiotics in human medicine and this was highlighted in the joint report on resistance from the Department of Health (DoH) and Defra.
"However, we are not complacent about the role of antibiotic use in veterinary medicine and we are one of the leading voices in the campaign for the responsible use of antibiotics in all species.
"We remain committed to the One Health principle and the need for the medical and veterinary professions to work together to tackle antimicrobial resistance. BVA and our specialist divisions are currently working on a plan to deliver the five-year strategy on AMR from the veterinary perspective. The actions being taken have been published along with those of our partners in the RUMA response to the DoH/Defra strategy.
"One of our key aims for the strategy will be to promote the importance of evidence-based responsible use among both vets and their clients. We are already encouraging education on minimising resistance and principles of responsible use through engagement with the veterinary schools and other stakeholders, and through our own continuing professional development (CPD) programme.
"The use of antibiotics in veterinary medicine in Europe in the future may well be different to how we have used them in the past, with certain constraints on certain classes of critically important medicines used in man. We will cooperate in adapting to this new environment but any changes must be based on sound scientific risk analysis and not on misrepresentation of the evidence, or at worse falsification of that evidence."
Another key action for BVA is the updating of BVA's responsible use guidance for the veterinary profession, and BVA's species divisions continue to work on advice tailored to their particular sectors.
BVA is also continuing to call for quicker, cheaper and more accessible accurate sensitivity and pen-side testing for veterinary use, and repeated this call in recent submissions to the Science & Technology Select Committee and the APPG on Eggs, Pigs and Poultry.
BVA has also agreed in principle that antibiotic use should be recorded and reported and will consider how such recording and reporting may be encouraged, how usage may be measured and audited, and how prescribing habits can be assessed. Such measures will help us to monitor trends in resistance development and track the progress we can make in addressing the problem.
All entrants to the survey will also be able to enter a draw to win a £50 Amazon voucher.
Jenny Langridge (pictured), Editor of Veterinary Woman, said: “This is our third annual survey and we are seeking the opinions of both Veterinary Woman readers and the wider professions to highlight the key issues affecting women in the veterinary sector.
"We’re not just asking questions, we’re offering veterinary professionals a chance to take part in an ongoing conversation about the very real issues that women face in the veterinary workplace.
"The more diverse the information we can collate about these topics, the more we can work towards achieving changes that help for women to thrive in the professions.”
All data and responses will remain strictly anonymous.
https://bit.ly/vet-woman-readership-survey
Researchers from the University of Bristol have published the results of a study which has identified risk factors for syringomyelia (SM) and which could help breeders select away from characteristics which predispose dogs to the disease.
Syringomyelia, which more commonly affects toy breeds such as the Cavalier King Charles Spaniel and the Chihuahua, causes fluid-filled cavities in the spinal cord. In these toy breeds, SM is usually secondary to a specific malformation of the skull called Chiari-like Malformation (CM).
The research looked at the relationship between head shape and the incidence of CM/SM. Dogs were measured in several countries using a standardised "bony landmark" measuring system and photos analysed by researchers.
The researchers found two significant risk factors associated with CM/SM in the skull shape of the CKCS: brachycephaly (the broadness of the top of skull relative to its length) and the distribution of doming of the skull. The study suggests that brachycephaly, with resulting doming towards the front of the head, is associated with CM/SM.
Thomas Mitchell, the undergraduate student who conducted the study under the supervision of Dr Clare Rusbridge, said: "Dog breeders are very experienced at selecting for a certain conformation or appearance in dogs. Our findings may allow breeders to select away from the condition over fewer generations by choosing appropriate matings and offspring to continue breeding programmes. The identification of an appearance that might protect against developing the disease is a significant step forward in tackling this painful condition.
"The study also provides guidance to breed clubs, breeders and judges that have a responsibility to avoid obvious conditions or exaggerations which would be harmful in any way to the health, welfare or soundness of the breed. It will also provide vets with verified advice to provide to breeders outside the show ring and to occasional hobbyists."
The study has been published online in the journal Canine Genetics and Epidemiology, and a video animation which shows the differences in head shape is available on YouTube.
The work was funded by a grant from the Kennel Club Charitable Trust and the Companion Cavalier Club provided a grant for the publication of the research.
Reference